NCT06313827 e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
| NCT ID | NCT06313827 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Valencia |
| Condition | Cystic Fibrosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-10-01 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to analyse the impact of a telematic assessment and monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early, thus preventing loss of lung function and maintaining quality of life. Participants will be assigned to one of 3 study groups: Control group (CG-1): will receive their usual physiotherapy treatment; Treatment group (TG-2): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment; Treatment and follow-up group (TGF-3): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment, plus telematic control of exacerbations with feedback from the physiotherapist.
Eligibility Criteria
Inclusion Criteria: * Diagnosed cystic fibrosis * Family access to an internet-enabled device * Camera and microphone * Absence of exacerbations in the last 30 days Exclusion Criteria: * Patients with lung transplant or on the waiting list for lung transplantation * Previous eye surgery (3 months) * Hemothorax * Active infection or inflammatory process * Tumors * Cognitive problems that make it impossible for them to use telematic devices.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06313827 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Cystic Fibrosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06313827 currently recruiting?
Yes, NCT06313827 is actively recruiting participants. Contact the research team at francisco.m.martinez@uv.es for enrollment information.
Where is the NCT06313827 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT06313827 clinical trial?
NCT06313827 is sponsored by University of Valencia. The trial plans to enroll 60 participants.